Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …

Stem cells serve as a source of cellular material in embryogenesis and postnatal growth and
regeneration. This requires significant proliferative potential ensured by sufficient telomere …

Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by myofibroblast
abnormal activation and extracellular matrix deposition. However, the pathogenesis of PF …

Accumulation of DNA damage in the lung induces cellular senescence and promotes age-
related diseases such as idiopathic pulmonary fibrosis (IPF). Hence, understanding the …

Idiopathic pulmonary fibrosis (IPF) is a chronic and lethal lung disease with limited treatment
options. The onset of IPF increases with age, indicating that aging is a major risk factor for …

Background: Unraveling the genetic background in a significant proportion of patients with
both sporadic and familial IPF provided new insights into the pathogenic pathways of …

Background/Aim: There is concern that people who had COVID-19 will develop pulmonary
fibrosis. Using mouse models, we compared pulmonary inflammation following injection of …

Fibrosis is a pathological process that affects multiple organs and is considered one of the
major causes of morbidity and mortality in multiple diseases, resulting in an enormous …

Background Autopsies can shed light on the pathogenesis of new and emerging diseases.
Aim To describe needle core necropsy findings of the lung, heart, and liver in decedents with …

Background The rapid increase in production and application of carbon nanotubes (CNTs)
has led to wide public concerns in their potential risks to human health. Single-walled CNTs …